Home/Chemotherapy Research and Practice/Article Record
Peer-Reviewed Article February 11, 2012

β-Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: Chemotherapy Research and Practice
Publisher: Hindawi Publishing Corporation • Egypt • 2090-2107
DOI: https://doi.org/10.1155/2012/192362

Abstract

Glioblastoma multiforme (GBM) is a commonly occurring brain tumor with a poor prognosis. GBM can develop both "de novo" or evolve from a previous astrocytoma and is characterized by high proliferation and infiltration into the surrounding tissue. Following treatment (surgery, radiotherapy, and chemotherapy), tumors often reappear. Glioma-initiating cells (GICs) have been identified in GBM and are thought to be responsible for tumors initiation, their continued growth, and recurrence. β-catenin, a component of the cell-cell adhesion complex and of the canonical Wnt pathway, regulates proliferation, adhesion, and migration in different cell types. β-catenin and components of the Wnt canonical pathway are commonly overexpressed in GBM. Here, we review previous work on the role of Wnt/β-catenin signalling in glioma initiation, proliferation, and invasion. Understanding the molecular mechanisms regulating GIC biology and glioma progression may help in identifying novel therapeutic targets for GBM treatment.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

97
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.